Perinatal exposure to environmental endocrine disruptor bisphenol A aggravates the onset of non-alcoholic fatty liver disease (NAFLD) in weanling F1 offspring of obese rats
暂无分享,去创建一个
[1] Minmin Li,et al. Bisphenol A and the Risk of Obesity a Systematic Review With Meta-Analysis of the Epidemiological Evidence , 2020, Dose-response : a publication of International Hormesis Society.
[2] P. Erkekoğlu,et al. Histopathologic, apoptotic and autophagic, effects of prenatal bisphenol A and/or di(2-ethylhexyl) phthalate exposure on prepubertal rat testis , 2020, Environmental Science and Pollution Research.
[3] Rahul Kumar,et al. Association of high-sensitivity C-reactive protein (hs-CRP) with non-alcoholic fatty liver disease (NAFLD) in Asian Indians: A cross-sectional study , 2020, Journal of family medicine and primary care.
[4] S. Raisuddin,et al. Transgenerational effect of parental obesity and chronic parental bisphenol A exposure on hormonal profile and reproductive organs of preadolescent Wistar rats of F1 generation: A one-generation study , 2020, Human & experimental toxicology.
[5] L. Aleya,et al. Ginger extract ameliorates bisphenol A (BPA)-induced disruption in thyroid hormones synthesis and metabolism: Involvement of Nrf-2/HO-1 pathway. , 2019, The Science of the total environment.
[6] M. Filipič,et al. Genotoxic activity of bisphenol A and its analogues bisphenol S, bisphenol F and bisphenol AF and their mixtures in human hepatocellular carcinoma (HepG2) cells. , 2019, The Science of the total environment.
[7] Xinghai Chen,et al. The adverse health effects of bisphenol A and related toxicity mechanisms. , 2019, Environmental research.
[8] Shikha Sharma,et al. Dichotomy of bisphenol A-induced expression of peroxisome proliferator-activated receptors in hepatic and testicular tissues in mice. , 2019, Chemosphere.
[9] L. Hoepner,et al. Bisphenol a: A narrative review of prenatal exposure effects on adipogenesis and childhood obesity via peroxisome proliferator-activated receptor gamma. , 2019, Environmental research.
[10] B. Ritz,et al. Prenatal Bisphenol A Exposure in Mice Induces Multi-tissue Multi-omics Disruptions Linking to Cardiometabolic Disorders , 2018, bioRxiv.
[11] B. Hansen,et al. Does obesity cause type 2 diabetes mellitus (T2DM)? Or is it the opposite? , 2018, Pediatric diabetes.
[12] L. Marroqui,et al. Timing of Exposure and Bisphenol-A: Implications for Diabetes Development , 2018, Front. Endocrinol..
[13] Shikha Sharma,et al. In silico molecular interaction of bisphenol analogues with human nuclear receptors reveals their stronger affinity vs. classical bisphenol A , 2018, Toxicology mechanisms and methods.
[14] Sarika Gupta,et al. The protective effect of α-lipoic acid against bisphenol A-induced neurobehavioral toxicity , 2018, Neurochemistry International.
[15] L. Lind,et al. Low‐dose developmental bisphenol A exposure alters fatty acid metabolism in Fischer 344 rat offspring , 2018, Environmental research.
[16] A. Hegazy,et al. The molecular mechanisms of action of the endocrine disrupting chemical bisphenol A in the development of cancer. , 2018, Gene.
[17] N. Chattipakorn,et al. Damaging Effects of Bisphenol A on the Kidney and the Protection by Melatonin: Emerging Evidences from In Vivo and In Vitro Studies , 2018, Oxidative medicine and cellular longevity.
[18] Shikha Sharma,et al. Endocrine-disrupting chemicals in food and their toxicological implications , 2017 .
[19] Youfa Wang,et al. A Systematic Examination of the Association between Parental and Child Obesity across Countries. , 2017, Advances in nutrition.
[20] Ning Wang,et al. Insights into the Role and Interdependence of Oxidative Stress and Inflammation in Liver Diseases , 2016, Oxidative medicine and cellular longevity.
[21] G. Muscogiuri,et al. Influence of Bisphenol A on Type 2 Diabetes Mellitus , 2016, International journal of environmental research and public health.
[22] Zhiyong Gong,et al. Toxicological evaluation of advanced glycation end product Nε-(carboxymethyl)lysine: Acute and subacute oral toxicity studies. , 2016, Regulatory toxicology and pharmacology : RTP.
[23] K. Walsh,et al. Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease. , 2016, Circulation research.
[24] Yunfeng Lin,et al. Peroxisome Proliferator-Activated Receptor-γ: Master Regulator of Adipogenesis and Obesity. , 2016, Current stem cell research & therapy.
[25] C. Calhau,et al. High-fat diet-induced obesity Rat model: a comparison between Wistar and Sprague-Dawley Rat , 2016, Adipocyte.
[26] Michael J Krashes,et al. Melanocortin-4 receptor–regulated energy homeostasis , 2016, Nature Neuroscience.
[27] D. Sellayah,et al. Role of FTO in Adipocyte Development and Function: Recent Insights , 2015, International journal of endocrinology.
[28] Ning Wang,et al. The Role of Oxidative Stress and Antioxidants in Liver Diseases , 2015, International journal of molecular sciences.
[29] J. Antignac,et al. Determination of bisphenol A and related substitutes/analogues in human breast milk using gas chromatography-tandem mass spectrometry , 2015, Analytical and Bioanalytical Chemistry.
[30] Alan D. Lopez,et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2014, The Lancet.
[31] I. Bergin,et al. Dose-Dependent Incidence of Hepatic Tumors in Adult Mice following Perinatal Exposure to Bisphenol A , 2014, Environmental health perspectives.
[32] J. Ludwicki,et al. Endocrine disruptors in food contact materials; is there a health threat? , 2014, Roczniki Panstwowego Zakladu Higieny.
[33] Julia A. Taylor,et al. Metabolic disruption in male mice due to fetal exposure to low but not high doses of bisphenol A (BPA): evidence for effects on body weight, food intake, adipocytes, leptin, adiponectin, insulin and glucose regulation. , 2013, Reproductive toxicology.
[34] Carlos Sonnenschein,et al. Perinatally Administered Bisphenol A as a Potential Mammary Gland Carcinogen in Rats , 2013, Environmental health perspectives.
[35] M. Bartolomei,et al. Bisphenol A Exposure Disrupts Genomic Imprinting in the Mouse , 2013, PLoS genetics.
[36] L. Fellmann,et al. Murine models for pharmacological studies of the metabolic syndrome. , 2013, Pharmacology & therapeutics.
[37] Michael K. Skinner,et al. Plastics Derived Endocrine Disruptors (BPA, DEHP and DBP) Induce Epigenetic Transgenerational Inheritance of Obesity, Reproductive Disease and Sperm Epimutations , 2013, PloS one.
[38] Gretchen A. Stevens,et al. National, regional, and global trends in adult overweight and obesity prevalences , 2012, Population Health Metrics.
[39] Philippe Lecomte,et al. A review of dietary and non-dietary exposure to bisphenol-A. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[40] Y. Soejima,et al. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. , 2012, World journal of gastroenterology.
[41] Laura N. Vandenberg,et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. , 2012, Endocrine reviews.
[42] Michael K. Skinner,et al. Transgenerational Actions of Environmental Compounds on Reproductive Disease and Identification of Epigenetic Biomarkers of Ancestral Exposures , 2012, PloS one.
[43] A. Baranova,et al. Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults , 2011, Alimentary pharmacology & therapeutics.
[44] Ian M. Morison,et al. Integrated Genetic and Epigenetic Analysis Identifies Haplotype-Specific Methylation in the FTO Type 2 Diabetes and Obesity Susceptibility Locus , 2010, PloS one.
[45] H. Yki-Järvinen. Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data , 2010, Current opinion in clinical nutrition and metabolic care.
[46] Eileen M. Burd,et al. Validation of Laboratory-Developed Molecular Assays for Infectious Diseases , 2010, Clinical Microbiology Reviews.
[47] I. Quesada,et al. Bisphenol A Exposure during Pregnancy Disrupts Glucose Homeostasis in Mothers and Adult Male Offspring , 2010, Environmental health perspectives.
[48] Laura N. Vandenberg,et al. Urinary, Circulating, and Tissue Biomonitoring Studies Indicate Widespread Exposure to Bisphenol A , 2010, Environmental health perspectives.
[49] G. Vanage,et al. Perinatal exposure of rats to Bisphenol A affects the fertility of male offspring. , 2009, Life sciences.
[50] Hina Rashid,et al. Iron deficiency augments bisphenol A-induced oxidative stress in rats. , 2009, Toxicology.
[51] D. Kang,et al. Effects of bisphenol A on breast cancer and its risk factors , 2009, Archives of Toxicology.
[52] K. Reynolds,et al. Global burden of obesity in 2005 and projections to 2030 , 2008, International Journal of Obesity.
[53] F. Foufelle,et al. SREBP-1c Transcription Factor and Lipid Homeostasis: Clinical Perspective , 2007, Hormone Research in Paediatrics.
[54] C. M. Galhardi,et al. Anthropometrical parameters and markers of obesity in rats , 2007, Laboratory animals.
[55] O. Cummings,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.
[56] H. El‐Serag,et al. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. , 2004, Gastroenterology.
[57] Brian P. Mulhall,et al. Nonalcoholic steatohepatitis , 2004, Current treatment options in gastroenterology.
[58] Y. Taketani,et al. Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. , 2002, Human reproduction.
[59] L. N. Valenti,et al. Tumor necrosis factor α promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease , 2002 .
[60] L. N. Valenti,et al. Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease. , 2002, Gastroenterology.
[61] Ho-Chul Shin,et al. Evaluation of developmental toxicity in rats exposed to the environmental estrogen bisphenol A during pregnancy. , 2001, Life sciences.
[62] Y. Hashimoto,et al. Estrogenic activity of dental materials and bisphenol-A related chemicals in vitro. , 2000, Dental materials journal.
[63] Y. Nakagawa,et al. Metabolism and cytotoxicity of bisphenol A and other bisphenols in isolated rat hepatocytes , 2000, Archives of Toxicology.
[64] S Z Cagen,et al. The relative bioavailability and metabolism of bisphenol A in rats is dependent upon the route of administration. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.
[65] Obert,et al. PREDICTING OBESITY IN YOUNG ADULTHOOD FROM CHILDHOOD AND PARENTAL OBESITY , 2000 .
[66] R. Cone,et al. Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice , 1997, Cell.
[67] T. Mantle,et al. Glutathione S-transferases. , 1990, Biochemical Society transactions.
[68] G. Duggin,et al. Low activities of glutathione-related enzymes as factors in the genesis of urinary bladder cancer. , 1984, Cancer research.
[69] C. Nations,et al. Activity of some dehydrogenase enzymes in mitochondria from Physarum polycephalum. , 1979, Comparative biochemistry and physiology. B, Comparative biochemistry.
[70] M. Uchiyama,et al. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. , 1978, Analytical biochemistry.
[71] B. Mannervik,et al. Purification and characterization of the flavoenzyme glutathione reductase from rat liver. , 1975, The Journal of biological chemistry.
[72] W B Jakoby,et al. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. , 1974, The Journal of biological chemistry.
[73] D. Jollow,et al. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. , 1974, Pharmacology.
[74] I. Fridovich,et al. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. , 1972, The Journal of biological chemistry.
[75] P. J. Randle,et al. Immunoassay of insulin with insulin antibody preciptate. , 1963, Lancet.